Waltham-based Thermo is buying the business from Solventum, a Minnesota-based company that spun off from manufacturing ...

M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to ...

On the heels of a move to reduce its viral vector manufacturing workforce, Thermo Fisher is beefing up its biologics ...

Key Takeaways Shares of Solventum rose Tuesday after the company agreed to sell its filtration and purification business to ...

Solventum Corp., 3M’s medtech spinoff, has sold its purification and filtration business to Massachussetts-based Thermo ...

Wall Street applauded the deal, sending shares of Solventum, the 3M spinoff, up 10% on Tuesday.

Thermo Fisher Scientific plans to acquire Solventum's Purification and Filtration business for $4.1 billion in cash.

Trian Fund Management, which beneficially owns about 5% of Solventum (SOLV) and is the company’s largest active shareholder, commented on ...

Trian Fund Management, L.P. (“Trian”), which beneficially owns ~5% of Solventum Corporation (NYSE: SOLV) (“Solventum” or the “Company”) and is the Company’s largest active shareholder, commented on ...

Thermo Fisher Scientific has a market capitalization of about $203.5 billion. Shares (NYSE: TMO) at midday Wednesday were trading around $532, which is near the bottom of their 52-week range.

Shares in Solventum rallied after Thermo Fisher Scientific said it would buy the healthcare company's purification and filtration business for about $4.1 billion. Solventum was spun off from 3M last ...

M health care spinoff Solventum says it will sell the business unit to Massachusetts-based Thermo Fisher Scientific Inc.